Private biotech market becoming frothy, says Sarissa's Alex Denner

Name: Private biotech market becoming frothy, says Sarissa's Alex Denner
Uploaded: 2021-10-06T15:10:29.000Z
Duration: 5 min 25 s
Description: Sarissa Capital Management’s Alex Denner explains why the private biotech market is becoming "quite frothy" amid the Covid-19 pandemic with CNBC's David Faber. The two spoke at the Active-Passive Investor Summit in New York City.

Sarissa Capital Management’s Alex Denner explains why the private biotech market is becoming "quite frothy" amid the Covid-19 pandemic with CNBC's David Faber. The two spoke at the Active-Passive Investor Summit in New York City.

05:25

Wed, Oct 6 202111:10 AM EDT

David Faber